Most people assume that if a drug were dangerous for them specifically, someone would have told them by now. Malignant hyperthermia (MH) is the exception that breaks that assumption completely. It's a rare but potentially fatal reaction triggered by volatile anesthetic gases — sevoflurane, desflurane, isoflurane — and the muscle relaxant succinylcholine, both routinely used in general anesthesia for everything from wisdom teeth removal to major surgery.
The catch: nothing about MH shows up until you're exposed to the trigger. You can go through childhood, adulthood, and multiple prior surgeries with zero symptoms, and then have a severe reaction on a completely unremarkable procedure — because susceptibility isn't about the surgery, it's written into your DNA the whole time.
What's actually happening in the body
In people with a pathogenic RYR1 variant, the mutated calcium channel in skeletal muscle cells stays open when it shouldn't. Triggering anesthetics cause a flood of calcium into muscle cells, which locks muscles into sustained contraction, spikes carbon dioxide production, and can send core body temperature climbing more than 0.5°C every 15 minutes — often past 40°C (104°F). Left untreated, it progresses to muscle breakdown, organ failure, and can be fatal.
How common is this, really?
MH reactions themselves are rare in absolute terms — clinical incidence during anesthesia ranges from roughly 1 in 5,000 to as low as 1 in 100,000, depending on the population and anesthetic protocol studied. But that number describes reactions that actually occur, not the number of people who carry the underlying genetic susceptibility. Using large-scale population sequencing data, researchers now estimate that as many as 1 in 1,149 people worldwide carry a pathogenic RYR1 or CACNA1S variant — a genetic burden far higher than clinical incidence alone would suggest, because most carriers simply haven't been exposed to a triggering combination of drugs yet.
Given that the vast majority of people will receive general anesthesia at some point in their life — a surgery, a colonoscopy, a dental procedure — that gap between "carries the risk" and "has had the reaction" is exactly the danger zone.
Why this belongs on your radar before you need it
Genetic testing for RYR1 and the related CACNA1S and STAC3 genes has become the recommended first-line approach for confirming MH susceptibility, replacing the older muscle biopsy contracture test in many cases. The American College of Medical Genetics and Genomics specifically recommends that pathogenic RYR1 and CACNA1S variants be reported back to patients when found — even as an incidental finding from testing done for an unrelated reason — precisely because the information changes how a future anesthesia team should manage your case.
If you know beforehand
Your anesthesia team uses non-triggering agents from the start. No crisis, no emergency dantrolene, no ICU stay.
If you don't know
The reaction happens mid-procedure. Recognition and response speed become the only thing standing between you and organ failure.
This is exactly the kind of thing a WGS report catches
RYR1 is one of dozens of medically actionable genes flagged in ACMG secondary findings — the kind of result you'd want in hand before an anesthesiologist ever asks "any reactions to anesthesia in the family?"
Get Your Whole Genome Sequenced → Use code GENOME for 10% off at Dante LabsWhat to do if you test positive
- Get a MedicAlert bracelet or card noting MH susceptibility — this is standard practice for confirmed carriers.
- Tell every anesthesia provider before every procedure, even routine ones. Non-triggering anesthesia protocols exist and work well.
- Confirm with clinical-grade testing before treating a raw DNA file result as definitive — RYR1 has dozens of documented pathogenic variants, and interpretation matters.
- Consider testing close relatives. MH susceptibility is inherited in an autosomal dominant pattern, meaning first-degree relatives have a 50% chance of carrying the same variant.
Most genetic risks give you decades of runway to act. This one is different — it's silent until the exact moment it isn't, in a setting where every minute matters. That's precisely the kind of finding whole genome sequencing exists to surface before you're the one finding out the hard way.